Production of macrocyclic ketones in recombinant hosts
AssigneeTakasago International Corporation
InventorsCurt aimé Friis NIELSEN, Jon HEAL, Johannes HAERLE
Life of this patent
Estimating the term…
Abstract
The invention relates to recombinant microorganisms and methods for producing macrocyclic ketones and macrocyclic ketone precursors.
Claims35
A recombinant host cell producing one or more macrocyclic ketone precursors and/or one or more macrocyclic ketones, comprising:
- (a) a gene encoding a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine;
- (b) a gene encoding a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate;
- (c) a gene encoding a polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal;
- (d) a gene encoding a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid;
- (e) a gene encoding a polypeptide capable of synthesizing an anteiso fatty acid from (S)-2-methylbutyryl-CoA;
- (f) a gene encoding a polypeptide capable of synthesizing a dicarboxylic acid (DCA) from the anteiso fatty acid or from an iso fatty acid;
- (g) a gene encoding a polypeptide capable of synthesizing a CoA activated DCA (DCA-CoA) from the DCA;
- (h) a gene encoding a polypeptide having cyclisation activity capable of synthesizing a muscone from the DCA;
- and/or
- (i) a gene encoding a polypeptide having cyclisation activity capable of synthesizing the muscone from the DCA-CoA;
- wherein at least one of the genes is a recombinant gene.
An in vitro method for producing a one or more macrocyclic ketone precursors and/or a one or more macrocyclic ketones a dicarboxylic acid (DCA), a CoA activated DCA (DCA-CoA), an anteiso fatty acid, or a combination thereof, comprising adding:
- (a) a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine and having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
- (b) a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate and having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
- (c) a polypeptide capable of synthesizing 2-methylbutyric acid from (S)-2-methylbutanal and having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
- (d) a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid and having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
- (e) a polypeptide capable of synthesizing the anteiso fatty acid from (S)-2-methylbutyryl-CoA and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
- (f) a polypeptide capable of synthesizing the DCA from the anteiso fatty acid or from the iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:
- 21, 22, 41, 42, 43, 44, 45, or 46;
- (g) a polypeptide capable of synthesizing the DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
- (h) a polypeptide capable of synthesizing the muscone from the CoA activated DCA;
- and/or
- (i) a polypeptide capable of synthesizing the muscone from DCA;
- and a plant-derived or synthetic L-isoleucine, (S)-2-methylbutyric acid, 3-methyl-2-oxopentanoate, (S)-2-methylbutanal, (S)-2-methylbutyric acid, (S)-2-methylbutyryl-CoA, an anteiso fatty acid, an iso fatty acid, a DCA or a DCA-CoA to a reaction mixture;
- wherein at least one of the polypeptides is a recombinant polypeptide;
- and synthesizing the one or more macrocyclic ketone precursors and/or the one or more macrocyclic ketones, the DCA, the DCA-CoA, the anteiso fatty acid, or the combination thereof.
A nucleic acid molecule encoding:
- (a) a polypeptide capable of synthesizing 3-methyl-2-oxopentanoate from L-isoleucine and having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
- (b) a polypeptide capable of synthesizing (S)-2-methylbutanal from 3-methyl-2-oxopentanoate and having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
- (c) a polypeptide capable of synthesizing (S)-2-methylbutyric acid from (S)-2-methylbutanal and having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
- (d) a polypeptide capable of synthesizing (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid and having at least 65% sequence identity to the amino acid sequence of SEQ ID NOs:23 or 24;
- (e) a polypeptide capable of synthesizing an anteiso fatty acid from (S)-2-methylbutyryl-CoA and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
- (f) a polypeptide capable of synthesizing a DCA from the anteiso fatty acid or from an iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:
- 21, 22, 41, 42, 43, 44, 45, or 46;
- (g) a polypeptide capable of synthesizing a DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
- (h) a polypeptide capable of synthesizing a muscone from the DCA;
- and/or
- (i) a polypeptide capable of synthesizing a muscone from the DCA-CoA.
A purified polypeptide or a catalytically active portion thereof capable of producing:
- (a) 3-methyl-2-oxopentanoate from L-isoleucine and having at least 90% sequence identity to any one of the amino acid sequences of SEQ ID NOs:34 or 35;
- (b) (S)-2-methylbutanal from 3-methyl-2-oxopentanoate and having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:36;
- (c) 2-methylbutyric acid from (S)-2-methylbutanal and having at least 95% sequence identity to any one of the amino acid sequences of SEQ ID NOs:37 or 38;
- (d) (S)-2-methylbutyryl-CoA from (S)-2-methylbutyric acid and having at least 65% sequence identity to any one of the amino acid sequences of SEQ ID NOs:23 or 24;
- (e) an anteiso fatty acid from (S)-2-methylbutyryl-CoA and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:25, 26, 27, 28, 29, 30, 31, or 32;
- (f) a DCA from the anteiso fatty acid or from the iso fatty acid and having at least 60% sequence identity to any one of the amino acid sequences of SEQ ID NOs:21, 22, 41, 42, 43, 44, 45, and 46;
- (g) a DCA-CoA from the DCA and having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:33;
- (h) a muscone from the DCA-CoA;
- and/or
- (i) the muscone from the DCA.
Dependencies are inferred from the claim text.